AEHR insider files to sell 15,000 shares

Rhea J Posedel filed a Form 144 seeking to sell 15,000 shares of Common Stock of AEHR through Oppenheimer & Co. The filing also reports sales in the past three months: 30,000 shares on 04/09/2026 for $2,100,000 and 13,998 shares on 02/13/2026 for $390,404.22.

Rhea-AI Filing Summary

Rhea J Posedel filed a Form 144 seeking to sell 15,000 shares of Common Stock of AEHR through Oppenheimer & Co. The filing also reports sales in the past three months: 30,000 shares on 04/09/2026 for $2,100,000 and 13,998 shares on 02/13/2026 for $390,404.22.

Key Figures

Proposed sale: 15,000 shares Recent sale: 30,000 shares Recent sale: 13,998 shares +1 more

4 metrics

Proposed sale 15,000 shares to be sold through Oppenheimer & Co

Recent sale 30,000 shares sold on 04/09/2026 for $2,100,000

Recent sale 13,998 shares sold on 02/13/2026 for $390,404.22

Original issuance date 11/28/2018 date associated with compensation issuance

Key Terms

Form 144, issuer, compensation

3 terms

Form 144 regulatory

"144: Securities To Be Sold Common | Oppenheimer & Co"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

issuer financial

"Common | 11/28/2018 | compensation | issuer"

compensation financial

"Common | 11/28/2018 | compensation | issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AEHR's Form 144 filed by Rhea J Posedel report?

It reports a proposed sale of 15,000 shares of AEHR common stock through Oppenheimer & Co. The filing also discloses two recent sales totaling 43,998 shares on 02/13/2026 and 04/09/2026 with stated proceeds.

How many shares did Rhea J Posedel sell in the past three months (AEHR)?

The Form 144 lists two completed sales totaling 43,998 shares in the past three months. Those sales were 13,998 shares on 02/13/2026 and 30,000 shares on 04/09/2026 with reported proceeds.

What proceeds are disclosed for the recent AEHR share sales?

The filing shows proceeds of $390,404.22 for 13,998 shares sold on 02/13/2026 and $2,100,000 for 30,000 shares sold on 04/09/2026. The proposed sale has no proceeds figure listed in the excerpt.

Which broker is listed for the proposed AEHR sale in the Form 144?

The proposed sale of 15,000 shares is listed with Oppenheimer & Co as the broker/dealer. The excerpt ties the 15,000-share offering to that firm without additional distribution details.

When were the securities to be sold originally issued or granted?

The excerpt shows an issuance-related date of 11/28/2018 linked to the securities and the label compensation. It indicates the shares were granted or issued on that date under a compensation context.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 06:24 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001055117
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AEHR TEST SYSTEMS
SEC File Number	000-22893
Address of Issuer	400 KATO TERRACE FREMONT CALIFORNIA 94539
Phone	5106239400
Name of Person for Whose Account the Securities are To Be Sold	POSEDEL RHEA J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Oppenheimer & Co, Inc 85 Broad St New York NY 10004	15000	1210743.00	31453254	04/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/28/2018	compensation	issuer			15000	11/28/2018	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Rhea J Posedel 400 Kato Terrace Fremont CA 94539	Common	04/09/2026	30000	2100000.00
Rhea J Posedel 400 Kato Terrace Fremont CA 94539	Common	02/13/2026	13998	390404.22

144: Remarks and Signature

Remarks	POA on file, 4/16/26
Date of Notice	04/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rhea J Posedel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)